Source: Leukemia. Unidade: FMRP
Subjects: INIBIDORES DE ENZIMAS (FARMACOLOGIA), DOENÇAS DA MEDULA ESPINHAL (PATOLOGIA), BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TRAINA, Fabiola et al. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia, v. 28, n. 1, p. 78-87, 2014Tradução . . Disponível em: https://doi.org/10.1038/leu.2013.269. Acesso em: 18 nov. 2024.APA
Traina, F., Visconte, V., Elson, P., Tabarroki, A., Jankowska, A. M., Hasrouni, E., et al. (2014). Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia, 28( 1), 78-87. doi:10.1038/leu.2013.269NLM
Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, Sekeres MA, Advani AS, Kalaycio M, Copelan EA, Saunthararajah Y, Saad STO, Maciejewski JP, Tiu RV. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms [Internet]. Leukemia. 2014 ; 28( 1): 78-87.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/leu.2013.269Vancouver
Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, Sekeres MA, Advani AS, Kalaycio M, Copelan EA, Saunthararajah Y, Saad STO, Maciejewski JP, Tiu RV. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms [Internet]. Leukemia. 2014 ; 28( 1): 78-87.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/leu.2013.269
